Defiante

Defiante Farmaceutica is a specialty pharmaceutical company based in Funchal, Portugal, and operates as a subsidiary of the Alfasigma Group. The company focuses on the development and commercialization of treatments for metabolic disorders and rare diseases, particularly those involving carnitine deficiencies. It serves as a primary holder of intellectual property and marketing authorizations for the group's specialty portfolio, including the standard-of-care treatment Carnitor (levocarnitine). Defiante plays a critical role in the global distribution and regulatory management of orphan drugs for patients with end-stage renal disease and genetic metabolic errors. The company is integrated into Alfasigma's broader mission of addressing unmet medical needs in gastroenterology, vascular health, and specialty care.